DEERFIELD, Ill., Jan. 21, 2026 /PRNewswire/ — Baxter Healthcare is pleased to share the growing success of the room temperature storage configuration of Hemopatch Sealing Hemostat, launched earlier, this Summer, across Australia and New Zealand. Since its introduction, the product has been met with enthusiastic adoption by surgical teams who value convenience, versatility, and clinical performance.
Hemopatch Sealing Hemostat is a ready-to-use, absorbable collagen pad designed for tissue sealing and hemostasis.1 The new room temperature format eliminates the need for refrigeration, streamlining preparation and storage in operating rooms.1 Surgeons across the region are finding significant value in the product’s ability to manage mild to moderate bleeding scenarios with confidence.
“Hemopatch Sealing Hemostat is an excellent product that is quite versatile across many urological operations. The ability to handle venous bleeding across wide surfaces is great for patients and has allowed me to confidently use Hemopatch Sealing Hemostat,” said Urological Surgeon, A/Prof Matthew Roberts from Queensland, Australia.
Baxter is proud to deliver meaningful value to clinicians through innovations like Hemopatch Sealing Hemostat, and empowering surgical teams in achieving their desired patient outcomes. The product’s strong reception underscores our commitment to providing solutions that help save and sustain lives.
With a shelf life of up to 36 months and compatibility with both open and minimally invasive procedures, Hemopatch Sealing Hemostat continues to be a trusted tool in operating rooms across Australia and New Zealand.1
For more information on Hemopatch Sealing Hemostat,
Visit: https://advancedsurgery.baxter.eu/hemopatch
Reference:
- Hemopatch sealing hemostat Instructions for Use.
Manufacturer:
Baxter Healthcare SA
Thurgauerstrasse 130 Glattbrugg,
ZÜRICH, 8152 Switzerland
Class of Device: III
CE0123
This content is intended solely for healthcare professionals and should not be interpreted as medical advice. Please consult with a qualified healthcare provider for any health concerns.
Hemopatch sealing hemostat is approved for use only in selected countries. For specific information on the availability and regulatory status of Hemopatch sealing hemostat room temperature in your country, we recommend contacting your local Baxter Healthcare sales representative.
Baxter and Hemopatch are trademarks of Baxter International Inc. or its subsidiaries.
GBU-AS21-250032 (v1.0) 01/2026
Photo – https://mma.prnewswire.com/media/2859987/Hemopatch_OR.jpg
Photo – https://mma.prnewswire.com/media/2859988/HemopatchIRI_AU.jpg
View original content:https://www.prnewswire.com/apac/news-releases/baxters-room-temperature-hemopatch-sealing-hemostat-gains-momentum-in-australia-and-new-zealand-302660268.html
SOURCE Baxter International Inc.
